McGregor Took PEDs After 2021 Leg Break With Team Doctor's Support

Conor McGregor used performance-enhancing drugs during his recovery from the leg fracture he suffered in July 2021, and did so with the knowledge and support of his physician, Dr. Neal ElAttrache, according to a new report published on June 11, 2026.

McGregor, now 37, is one of the most recognizable figures in combat sports history. The Irishman fights out of SBG Ireland and holds a professional record of 22 wins and 6 losses. Competing as a southpaw at 175 cm with a 188 cm reach, he built his reputation on sharp, high-volume striking, averaging 5.32 significant strikes landed per minute at 49 percent accuracy across his career. The leg break, sustained during his trilogy bout with Dustin Poirier, has kept him sidelined for what has become an extraordinarily extended absence from competition.

Dr. ElAttrache is a well-regarded sports medicine physician with documented ties to professional American football and baseball organizations. The report places him at the center of McGregor's post-injury treatment protocol, indicating the PED use was not unsanctioned in a medical sense but was conducted under his direct guidance.

Why it matters

• McGregor has been out of competition since the 2021 injury, and the revelation raises questions about the nature of his recovery timeline and the substances involved.
• The involvement of a named physician adds a layer of institutional accountability to what would otherwise be a straightforward doping allegation.
• USADA and the UFC's anti-doping framework distinguish between therapeutic use and prohibited substance violations; how this report intersects with that framework remains unclear from available information.
• McGregor holds no current ranking in the UFC lightweight or welterweight divisions, but any return to the octagon would place this disclosure under immediate regulatory scrutiny.